120 related articles for article (PubMed ID: 35834175)
1. Population-Level Impact and Cost-effectiveness of Continuous Glucose Monitoring and Intermittently Scanned Continuous Glucose Monitoring Technologies for Adults With Type 1 Diabetes in Canada: A Modeling Study.
Rotondi MA; Wong O; Riddell M; Perkins B
Diabetes Care; 2022 Sep; 45(9):2012-2019. PubMed ID: 35834175
[TBL] [Abstract][Full Text] [Related]
2. Personalizing the Use of a Intermittently Scanned Continuous Glucose Monitoring Device in Individuals With Type 1 Diabetes: A Cost-Effectiveness Perspective in the Netherlands (FLARE-NL 9).
Emamipour S; van Dijk PR; Bilo HJG; Edens MA; van der Galiën O; Postma MJ; Feenstra TL; van Boven JFM
J Diabetes Sci Technol; 2024 Jan; 18(1):135-142. PubMed ID: 35815617
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and Safety of Continuous Glucose Monitoring and Intermittently Scanned Continuous Glucose Monitoring in Patients With Type 2 Diabetes: A Systematic Review and Meta-analysis of Interventional Evidence.
Seidu S; Kunutsor SK; Ajjan RA; Choudhary P
Diabetes Care; 2024 Jan; 47(1):169-179. PubMed ID: 38117991
[TBL] [Abstract][Full Text] [Related]
4. Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with insulin-treated Type II diabetes in France.
Alshannaq H; Pollock RF; Joubert M; Ahmed W; Norman GJ; Lynch PM; Roze S
J Comp Eff Res; 2024 Mar; 13(3):e230174. PubMed ID: 38294332
[No Abstract] [Full Text] [Related]
5. Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with insulin-treated Type 2 diabetes in Canada.
Alshannaq H; Isitt JJ; Pollock RF; Norman GJ; Cogswell G; Lynch PM; Roze S
J Comp Eff Res; 2023 Oct; 12(10):e230075. PubMed ID: 37668608
[No Abstract] [Full Text] [Related]
6. Self-Monitoring of Blood Glucose Requirements with the Use of Intermittently Scanned Continuous Glucose Monitoring.
Reddy M; Oliver N
Diabetes Technol Ther; 2020 Mar; 22(3):235-238. PubMed ID: 31833786
[TBL] [Abstract][Full Text] [Related]
7. A European Cost-Utility Analysis of the MiniMed™ 780G Advanced Hybrid Closed-Loop System Versus Intermittently Scanned Continuous Glucose Monitoring with Multiple Daily Insulin Injections in People Living with Type 1 Diabetes.
Jendle J; Buompensiere MI; Ozdemir Saltik AZ; de Portu S; Smith-Palmer J; Pollock RF; Cohen O
Diabetes Technol Ther; 2023 Dec; 25(12):864-876. PubMed ID: 37801658
[No Abstract] [Full Text] [Related]
8. The Cost-Effectiveness of an Advanced Hybrid Closed-Loop System Compared to Standard Management of Type 1 Diabetes in a Singapore Setting.
Gardner D; Lakkad M; Qiu Z; Inoue Y; Rama Chandran S; Wherry K
Diabetes Technol Ther; 2024 May; 26(5):324-334. PubMed ID: 38215206
[No Abstract] [Full Text] [Related]
9. Comparing the glycaemic outcomes between real-time continuous glucose monitoring (rt-CGM) and intermittently scanned continuous glucose monitoring (isCGM) among adults and children with type 1 diabetes: A systematic review and meta-analysis of randomized controlled trials.
Zhou Y; Sardana D; Kuroko S; Haszard JJ; de Block MI; Weng J; Jefferies C; Wheeler BJ
Diabet Med; 2024 Mar; 41(3):e15280. PubMed ID: 38197238
[TBL] [Abstract][Full Text] [Related]
10. Economic Value of Improved Accuracy for Self-Monitoring of Blood Glucose Devices for Type 1 Diabetes in Canada.
McQueen RB; Breton MD; Ott M; Koa H; Beamer B; Campbell JD
J Diabetes Sci Technol; 2015 Aug; 10(2):366-77. PubMed ID: 26275642
[TBL] [Abstract][Full Text] [Related]
11. Effects of 12-Week Freestyle Libre 2.0 in Children with Type 1 Diabetes and Elevated HbA1c: A Multicenter Randomized Controlled Trial.
Jefferies CA; Boucsein A; Styles SE; Chamberlain B; Michaels VR; Crockett HR; De Lange M; Lala A; Cunningham V; Wiltshire EJ; Serlachius AS; Wheeler BJ
Diabetes Technol Ther; 2023 Dec; 25(12):827-835. PubMed ID: 37782139
[No Abstract] [Full Text] [Related]
12. Long-Term Cost-Effectiveness of Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in Adults With Type 1 Diabetes in Iran.
Molaee MC; Naseri ZG; Karami MA
Value Health Reg Issues; 2024 May; 43():101002. PubMed ID: 38820700
[TBL] [Abstract][Full Text] [Related]
13. Do-it-yourself continuous glucose monitoring in people aged 16 to 69 years with type 1 diabetes: A qualitative study.
Sehgal S; Boucsein A; Styles S; Palmer O; Paul RG; Crocket H; de Bock M; Wheeler BJ
Diabet Med; 2024 Feb; 41(2):e15168. PubMed ID: 37393600
[TBL] [Abstract][Full Text] [Related]
14. To Use or Not to Use a Self-monitoring of Blood Glucose System? Real-world Flash Glucose Monitoring Patterns Using a Cluster Analysis of the FGM-Japan Study.
Sakane N; Hirota Y; Yamamoto A; Miura J; Takaike H; Hoshina S; Toyoda M; Saito N; Hosoda K; Matsubara M; Tone A; Kawashima S; Sawaki H; Matsuda T; Domichi M; Suganuma A; Sakane S; Murata T
Intern Med; 2023 Sep; 62(18):2607-2615. PubMed ID: 36631091
[TBL] [Abstract][Full Text] [Related]
15. Cost-utility analysis of a flash continuous glucose monitoring system in the management of people with type 2 diabetes mellitus on basal insulin therapy-An Italian healthcare system perspective.
Del Prato S; Giorgino F; Szafranski K; Poon Y
Diabetes Obes Metab; 2024 Jun; ():. PubMed ID: 38853717
[TBL] [Abstract][Full Text] [Related]
16. Associations between use of diabetes technology and diabetes distress: a Danish cross-sectional survey of adults with type 1 diabetes.
Lorenzen JT; Madsen KP; Cleal B; Joensen LE; Nørgaard K; Pedersen-Bjergaard U; Schmidt S; Rytter K; Willaing I
BMJ Open; 2024 Mar; 14(3):e080053. PubMed ID: 38531585
[TBL] [Abstract][Full Text] [Related]
17. Cost-utility analysis of Dexcom G6 real-time continuous glucose monitoring versus FreeStyle Libre 1 intermittently scanned continuous glucose monitoring in adults with type 1 diabetes in Belgium.
Visser MM; Van Muylder A; Charleer S; Isitt JJ; Roze S; De Block C; Maes T; Vanhaverbeke G; Nobels F; Keymeulen B; Mathieu C; Luyten J; Gillard P; Verhaeghe N
Diabetologia; 2024 Apr; 67(4):650-662. PubMed ID: 38236409
[TBL] [Abstract][Full Text] [Related]
18. Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European Association for the Study of Diabetes (EASD) and of the International Society for Pediatric and Adolescent Diabetes (ISPAD) endorsed by JDRF and supported by the American Diabetes Association (ADA).
Moser O; Riddell MC; Eckstein ML; Adolfsson P; Rabasa-Lhoret R; van den Boom L; Gillard P; Nørgaard K; Oliver NS; Zaharieva DP; Battelino T; de Beaufort C; Bergenstal RM; Buckingham B; Cengiz E; Deeb A; Heise T; Heller S; Kowalski AJ; Leelarathna L; Mathieu C; Stettler C; Tauschmann M; Thabit H; Wilmot EG; Sourij H; Smart CE; Jacobs PG; Bracken RM; Mader JK
Pediatr Diabetes; 2020 Dec; 21(8):1375-1393. PubMed ID: 33047481
[TBL] [Abstract][Full Text] [Related]
19. Association Between Adherence, A1C Improvement, and Type of Continuous Glucose Monitoring System in People with Type 1 Diabetes or Type 2 Diabetes Treated with Intensive Insulin Therapy.
Nemlekar PM; Hannah KL; Green CR; Norman GJ
Diabetes Ther; 2024 Mar; 15(3):639-648. PubMed ID: 38289464
[TBL] [Abstract][Full Text] [Related]
20. Long-term health economic evaluation of intermittently scanned glucose monitoring compared with self-monitoring blood glucose in a real-world setting in Finnish adult individuals with type 1 diabetes.
Mustonen J; Rautiainen PA; Lamidi ML; Lavikainen P; Martikainen J; Laatikainen T
Diabetes Technol Ther; 2024 Jun; ():. PubMed ID: 38842899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
